We investigated in patients in the randomized TWENTE trial the long-term safety and efficacy of treating bifurcation lesions with 2 widely applied second-generation drug-eluting stents , the zotarolimus-eluting Resolute stent ( Medtronic Inc , Santa Rosa , CA ) and the everolimus-eluting Xience V stent ( Abbott Vascular , Santa Clara , CA ) .